Celmatix
Dr. Charlotte Frank Sage has over 10 years of operations experience with companies focused on women’s health. She graduated with a B.A. from Wesleyan University and a Ph.D. from Yale University. After her graduate studies, she worked in operations at Extend Fertility, the first U.S. company to offer elective egg freezing. She joined Celmatix in 2013 and currently leads the clinical research operations for the PReM initiative. In this role, Dr. Frank Sage also oversees the company’s research and privacy compliance programs.
This person is not in any offices
Celmatix
Celmatix Inc. is a preclinical-stage women’s health biotech focused uniquely on ovarian biology. With a lead “pipeline-in-a-pill” AMHR2 program focused on ovarian senescence, and collaborations in PCOS and non-hormonal contraception with industry leaders, Celmatix is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in ovarian health.